When Trp is limiting, TDO2 is subject to proteasomal degradation to avert tryptophanemia.
By combining CRISPRi screening, biochemistry and cryo-EM, we discovered how Trp is perceived by binding to an exosite on TDO2 to control its phosphorylation-dependent ubiquitylation.
3/6